Indications
Infectious and inflammatory diseases of the oral cavity and pharynx: pharyngitis; laryngitis; catarrhal sore throat; stomatitis; ulcerative gingivitis; chronic tonsillitis (as an auxiliary agent).
$2.00
Active ingredient: | |
---|---|
Dosage form: | |
Indications for use: |
Out of stock
Add to wishlistInfectious and inflammatory diseases of the oral cavity and pharynx: pharyngitis; laryngitis; catarrhal sore throat; stomatitis; ulcerative gingivitis; chronic tonsillitis (as an auxiliary agent).
Pregnancy;
lactation (breastfeeding);
children under 4 years of age;
hypersensitivity to the components of the drug;
hypersensitivity to ammonia compounds.
of 1 tab. | |
benzoxonium chloride | 1 mg |
lidocaine hydrochloride | 1 mg |
Excipients:
sorbitol – 1 g (equivalent to approximately 17 kJ/4 kcal),
cellulose microcrystalline,20 mg,
macrogol 6000 – 25 mg,
corn starch – 55 mg,
sodium saccharin – 4 mg,
sodium chloride 10 mg,
citric acid – 5 mg,
magnesium stearate – 1 mg,
orange flavor – 40 mg.
Thera Flu LAR WITH ORANGE FLAVOR in the form of tablets-this is just 5 actions for sore throat *:
Thera Flu ® Lar thanks to the complex composition of antiseptic and anesthetic will help to relieve pain, affecting the cause (bacteria, viruses) and the consequence (symptoms). Active ingredients: Benzoxonium chloride 1 mg, lidocaine hydrochloride 1 mg. * Antiseptic, local anesthetic, antibacterial (Gram ( + ), Gram ( – )), antifungal, antiviral. Instructions for medical use, RU LS-002042 from 17.06.2011
of 1 tab. | |
benzoxonium chloride | 1 mg |
lidocaine hydrochloride | 1 mg |
Auxiliary substances:
sorbitol – 1 g (equivalent to approximately 17 kJ/4 kcal),
cellulose microcrystalline,20 mg,
macrogol 6000 – 25 mg,
corn starch – 55 mg,
sodium saccharin – 4 mg,
sodium chloride 10 mg,
citric acid – 5 mg,
magnesium stearate – 1 mg,
orange flavor – 40 mg.
Antiseptic drug for topical use in ENT practice. It is a quaternary ammonium salt: N-benzyl N-dodecyl N, N-di(2-hydroxyethyl) ammonium chloride. Due to its cationic structure, it has membranotropic activity and has a pronounced antibacterial effect on gram-positive and, to a lesser extent, gram-negative microorganisms. Benzoxonium also has antifungal and antiviral activity against membrane viruses (including influenza, parainfluenza and herpes viruses). Lidocaine is a local anesthetic that reduces pain in the throat when swallowing during inflammatory processes.
Benzoxonium chloride is practically not absorbed. In humans, the Active ingredient is not detected in the blood. No accumulation of the Active ingredient was detected in the body tissues. About 1% of the received dose of benzoxonium chloride is detected in the urine. Lidocaine is absorbed when taken orally and through the oral mucosa. It is metabolized during the” first pass” through the liver. When administered orally, the bioavailability is about 35%. Lidocaine metabolites are excreted together with urine, less than 10% of the Active ingredient is excreted unchanged.
Infectious and inflammatory diseases of the oral cavity and pharynx: pharyngitis; laryngitis; catarrhal sore throat; stomatitis; ulcerative gingivitis; chronic tonsillitis (as an auxiliary agent).
The drug is contraindicated for use in the first trimester of pregnancy and during lactation (breastfeeding). Adequate and strictly controlled clinical studies on the safety of the drug during pregnancy have not been conducted. The use of the drug in the second and third trimesters is not recommended. There are no clinical data on the excretion of active substances in breast milk. However, the drug is not recommended for use during breastfeeding. In experimental studies, no effect of the drug on the reproductive function and development of the fetus was found.
Pregnancy; lactation (breastfeeding); children under 4 years of age;hypersensitivity to the components of the drug;hypersensitivity to ammonia compounds.
Possible: local irritation; if used for more than 2 weeks – reversible brown coloration of the tongue and teeth. Rare: allergic reactions.
The effectiveness of benzoxonium chloride decreases with the simultaneous use of anionic-active agents, such as toothpaste.
Ethanol increases the absorption of benzoxonium chloride.
Inside. Single dose – 1 tablet every 2-3 hours. With severe symptoms of the disease, take 1 tablet every 1-2 hours. The tablet should slowly dissolve in the mouth. The daily dose should not exceed 10 tablets. Children: Thera Flu ® LAR can be used in children starting from 4 years of age,1 tablet every 2-3 hours. The daily dose should not exceed 6 tablets.
Symptoms: if accidentally ingested in high doses, nausea and vomiting may occur. The content of lidocaine in the drug is insignificant and can not cause serious symptoms of overdose. Treatment: it is recommended to drink milk or eat egg white whipped in water.
Tablets for resorption are white with a yellowish tinge, round, biconvex, with the Zyma logo (two triangles located opposite each other with some displacement) on one side and the code “OR” on the reverse side, with an orange smell.
During the use of the drug, alcohol consumption should be avoided.
8 tablets are packed in a blister of combined material PVC/ PE/PVDH /aluminum foil. Two blisters are placed together with the instructions for use in a pack of cardboard.
The drug should be stored out of the reach of children, in a dry place at a temperature not exceeding 30°C.
life is 3 years.
Benzalkonium Chloride, Lidocaine
Tablets
Children over 12 years old, For adults
Runny Nose, Cold, Sore Throat, Flu
Out of stock
Reviews
There are no reviews yet